{"Alzheimer's": [0, 49, 68, 100, 104, 284, 329], "disease": [1, 8, 101, 105, 285, 330], "is": [2, 15, 25], "a": [3, 19, 26, 219, 299], "progressive,": [4], "irreversible,": [5], "and": [6, 34, 43, 51, 80, 173, 181, 189, 191, 194, 228, 278, 307, 322], "fatal": [7], "for": [9, 94, 243], "which": [10, 108], "accumulation": [11], "of": [12, 37, 45, 62, 107, 163, 202, 210, 241, 261, 272, 283, 328], "amyloid": [13, 38, 88], "beta": [14], "thought": [16], "to": [17, 99, 118, 154, 225, 251, 266], "play": [18], "key": [20], "role": [21], "in": [22, 47, 64, 74, 238, 258, 281, 325, 333], "pathogenesis.": [23], "Aducanumab": [24], "human": [27], "monoclonal": [28], "antibody": [29], "directed": [30], "against": [31], "aggregated": [32], "soluble": [33], "insoluble": [35], "forms": [36], "beta.We": [39], "evaluated": [40], "the": [41, 112, 158, 206], "efficacy": [42, 214], "safety": [44, 178], "aducanumab": [46, 63, 120, 245], "early": [48, 67], "disease.EMERGE": [50], "ENGAGE": [52, 195, 259, 311], "were": [53, 114, 196], "two": [54], "randomized,": [55], "double-blind,": [56], "placebo-controlled,": [57], "global,": [58], "phase": [59], "3": [60], "studies": [61, 70], "patients": [65, 83], "with": [66], "disease.These": [69], "involved": [71], "348": [72], "sites": [73], "20": [75], "countries.Participants": [76], "included": [77, 177, 216], "1638": [78], "(EMERGE)": [79], "1647": [81], "(ENGAGE)": [82], "(aged": [84], "50-85": [85], "years,": [86], "confirmed": [87, 275], "pathology)": [89], "who": [90], "met": [91, 237], "clinical": [92, 183, 309], "criteria": [93], "mild": [95, 103], "cognitive": [96], "impairment": [97], "due": [98], "or": [102, 124, 135, 317], "dementia,": [106], "1812": [109], "(55.2%)": [110], "completed": [111], "study.Participants": [113], "randomly": [115], "assigned": [116], "1:1:1": [117], "receive": [119], "low": [121], "dose": [122, 130], "(3": [123], "6": [125], "mg/kg": [126, 132], "target": [127, 133, 276], "dose),": [128, 134], "high": [129], "(10": [131], "placebo": [136, 247], "via": [137], "IV": [138], "infusion": [139], "once": [140], "every": [141], "4": [142], "weeks": [143], "over": [144], "76": [145], "weeks.The": [146], "primary": [147, 234, 306, 316], "outcome": [148], "measure": [149], "was": [150, 236, 292, 331], "change": [151, 302], "from": [152, 205, 218, 296], "baseline": [153], "week": [155], "78": [156], "on": [157, 199], "Clinical": [159], "Dementia": [160], "Rating": [161], "Sum": [162], "Boxes": [164], "(CDR-SB),": [165], "an": [166], "integrated": [167], "scale": [168], "that": [169, 185], "assesses": [170], "both": [171, 334], "function": [172], "cognition.": [174], "Other": [175], "measures": [176], "assessments;": [179], "secondary": [180, 308, 318], "tertiary": [182], "outcomes": [184], "assessed": [186], "cognition,": [187], "function,": [188], "behavior;": [190], "biomarker": [192, 273], "endpoints.EMERGE": [193], "halted": [197], "based": [198], "futility": [200, 226], "analysis": [201], "data": [203, 217, 221], "pooled": [204], "first": [207], "approximately": [208], "50%": [209], "enrolled": [211], "patients;": [212], "subsequent": [213], "analyses": [215], "larger": [220], "set": [222], "collected": [223], "up": [224], "declaration": [227], "followed": [229], "prespecified": [230], "statistical": [231], "analyses.": [232], "The": [233, 287], "endpoint": [235], "EMERGE": [239, 297], "(difference": [240, 260], "-0.39": [242], "high-dose": [244], "vs": [246], "[95%": [248, 263], "CI,": [249, 264], "-0.69": [250], "-0.09;": [252], "P=.012;": [253], "22%": [254], "decrease])": [255], "but": [256], "not": [257, 313], "0.03,": [262], "-0.26": [265], "0.33;": [267], "P=.833;": [268], "2%": [269], "increase]).": [270], "Results": [271], "substudies": [274], "engagement": [277], "dose-dependent": [279], "reduction": [280, 324], "markers": [282, 327], "pathophysiology.": [286], "most": [288], "common": [289], "adverse": [290], "event": [291], "amyloid-related": [293], "imaging": [294], "abnormalities-edema.Data": [295], "demonstrated": [298], "statistically": [300], "significant": [301], "across": [303], "all": [304], "four": [305], "endpoints.": [310, 319], "did": [312], "meet": [314], "its": [315], "A": [320], "dose-": [321], "time-dependent": [323], "pathophysiological": [326], "observed": [332], "trials.": [335]}